Forward Pharma A/S (FWP)

The stock price of Forward Pharma A/S (NASDAQ: FWP) fell by almost 20% during the premarket.  Investors are responding negatively to the Technical Board of Appeal (TBA) of the European Patent Office (EPO), dismissing Forward's appeal to revoke the EP2801355 patent (355 patent) following the oral hearing.

The stock price of Forward Pharma A/S (NASDAQ:FWP) fell by over 20% pre-market. This is why it happened.

COPENHAGEN, Denmark, Sept. 06, 2021 (GLOBE NEWSWIRE) -- Forward Pharma A/S (NASDAQ:FWP) (“we,” “Forward” or the “Company”), today announced that the Technical Board of Appeal (the “TBA”) of the European Patent Office (the “EPO”) has dismissed Forward's appeal of the previous decision of the EPO Opposition Division to revoke the EP2801355 patent (the “'355 patent”) following the oral hearing.

COPENHAGEN, Denmark, April 14, 2021 (GLOBE NEWSWIRE) -- Forward Pharma A/S (NASDAQ:FWP) (“We,” “Forward” or the “Company” and, together with its subsidiaries, the “Group”), today reported consolidated financial results for the year ended December 31, 2020. Our net loss for the year ended December 31, 2020 was $6.4 million, or $0.07 per share, versus a net loss of $4.2 million, or $0.04 per share for the year ended December 31, 2019. Our research and development and general and administrative costs decreased from $5.3 million for the year ended December 31, 2019 to $3.4 million for the year ended December 31, 2020. Our net loss for the year ended December 31, 2020 was unfavorably impacted by a significant non-cash foreign exchange loss of $3.0 million that is primarily related to our U.S. Dollar cash holdings and the weakening of the U.S. Dollar compared to the Danish Kroner. “We continue to be well positioned financially as we enter into 2021 with cash holdings of $79.1 million and working capital of $78.6 million. We believe we have the financial strength to fund operations beyond 2021 and focus on the oral proceedings before the Technical Board of Appeals that are scheduled for September 6, 2021 after two postponements caused by the ongoing coronavirus pandemic,” said Dr. Claus Bo Svendsen, Chief Executive Officer of Forward.

COPENHAGEN, Denmark, Jan. 12, 2021 (GLOBE NEWSWIRE) -- Forward Pharma A/S (NASDAQ:FWP) (“we,” “Forward” or the “Company”), today announced that due to ongoing precautionary measures against the spread of the novel coronavirus (“COVID-19”), the Technical Board of Appeal (the “TBA”) of the European Patent Office (the “EPO”) again has rescheduled the oral hearing of the appeal against the decision of the Opposition Division that revoked the EP2801355 patent (the “'355 Patent”). The new hearing date is set for September 6, 2021.

Chr. Hansen Holding A/S (OTCMKTS:CHYHY) was upgraded by research analysts at Goldman Sachs Group from a “sell” rating to a “neutral” rating in a report issued on Tuesday, The Fly reports. A number of other brokerages have also issued reports on CHYHY. JPMorgan Chase & Co. restated an “underweight” rating on shares of Chr. Hansen […]

Chr. Hansen Holding A/S (OTCMKTS:CHYHY) has been assigned a consensus rating of “Hold” from the eight ratings firms that are covering the stock, Marketbeat reports. Three equities research analysts have rated the stock with a sell recommendation and five have given a hold recommendation to the company. A number of equities analysts have recently commented […]

Denmark stocks higher at close of trade; OMX Copenhagen 20 up 0.65%

Shares of Ascendis Pharma A/S (NASDAQ:ASND) have earned a consensus rating of “Buy” from the fourteen research firms that are presently covering the company, Marketbeat.com reports. One analyst has rated the stock with a sell recommendation, one has issued a hold recommendation and twelve have given a buy recommendation to the company. The average 12-month […]

Nuveen Asset Management LLC lowered its position in shares of Ascendis Pharma A/S (NASDAQ:ASND) by 31.3% in the second quarter, according to the company in its most recent disclosure with the SEC. The firm owned 12,105 shares of the biotechnology company’s stock after selling 5,523 shares during the quarter. Nuveen Asset Management LLC’s holdings in […]

Wall Street brokerages expect Ascendis Pharma A/S (NASDAQ:ASND) to post sales of $1.94 million for the current quarter, according to Zacks Investment Research. Three analysts have issued estimates for Ascendis Pharma A/S’s earnings, with the lowest sales estimate coming in at $1.18 million and the highest estimate coming in at $2.95 million. Ascendis Pharma A/S […]

Credit Suisse Group reaffirmed their neutral rating on shares of Chr. Hansen Holding A/S (OTCMKTS:CHYHY) in a report issued on Tuesday, The Fly reports. Several other research analysts have also issued reports on the company. Bank of America lowered Chr. Hansen Holding A/S from a neutral rating to an underperform rating in a research report […]

JBS S A/S (OTCMKTS:JBSAY) and Cal-Maine Foods (NASDAQ:CALM) are both consumer staples companies, but which is the better investment? We will contrast the two businesses based on the strength of their risk, earnings, analyst recommendations, dividends, profitability, institutional ownership and valuation. Profitability This table compares JBS S A/S and Cal-Maine Foods’ net margins, return on […]

JBS S A/S (OTCMKTS:JBSAY) and BIQI International (OTCMKTS:BIQIF) are both consumer staples companies, but which is the better investment? We will contrast the two companies based on the strength of their dividends, earnings, analyst recommendations, institutional ownership, profitability, valuation and risk. Institutional and Insider Ownership 0.1% of JBS S A/S shares are owned by institutional […]

Ascendis Pharma A/S (NASDAQ:ASND) was downgraded by research analysts at BidaskClub from a “buy” rating to a “hold” rating in a report issued on Saturday, BidAskClub reports. A number of other equities research analysts also recently weighed in on ASND. JPMorgan Chase & Co. started coverage on Ascendis Pharma A/S in a research report on […]

Oct 09, 2020 (The Expresswire) -- Global “Monoclonal Antibodies market” competitive landscape provides particulars and data information by players. The...